Literature DB >> 28387812

Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia.

Aniket Mishra1, Raffaele Ferrari2, Peter Heutink3,4, John Hardy2, Yolande Pijnenburg5, Danielle Posthuma1,6.   

Abstract

Genome-wide association studies in frontotemporal dementia showed limited success in identifying associated loci. This is possibly due to small sample size, allelic heterogeneity, small effect sizes of single genetic variants, and the necessity to statistically correct for testing millions of genetic variants. To overcome these issues, we performed gene-based association studies on 3348 clinically identified frontotemporal dementia cases and 9390 controls (discovery, replication and joint-cohort analyses). We report association of APOE and TOMM40 with behavioural variant frontotemporal dementia, and ARHGAP35 and SERPINA1 with progressive non-fluent aphasia. Further, we found the ɛ2 and ɛ4 alleles of APOE harbouring protective and risk increasing effects, respectively, in clinical subtypes of frontotemporal dementia against neurologically normal controls. The APOE-locus association with behavioural variant frontotemporal dementia indicates its potential risk-increasing role across different neurodegenerative diseases, whereas the novel genetic associations of ARHGAP35 and SERPINA1 with progressive non-fluent aphasia point towards a potential role of the stress-signalling pathway in its pathophysiology.
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  FTD; GWAS; MAGMA; gene-based association study; stress-signalling pathway

Mesh:

Substances:

Year:  2017        PMID: 28387812     DOI: 10.1093/brain/awx066

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  23 in total

Review 1.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

Review 2.  Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders.

Authors:  Juan Miguel Godoy-Corchuelo; Luis C Fernández-Beltrán; Zeinab Ali; María J Gil-Moreno; Juan I López-Carbonero; Antonio Guerrero-Sola; Angélica Larrad-Sainz; Jorge Matias-Guiu; Jordi A Matias-Guiu; Thomas J Cunningham; Silvia Corrochano
Journal:  Biomedicines       Date:  2022-05-10

Review 3.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

Review 4.  Immune Signaling in Neurodegeneration.

Authors:  Timothy R Hammond; Samuel E Marsh; Beth Stevens
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

5.  Recent advances in the genetics of frontotemporal dementia.

Authors:  Daniel W Sirkis; Ethan G Geier; Luke W Bonham; Celeste M Karch; Jennifer S Yokoyama
Journal:  Curr Genet Med Rep       Date:  2019-01-30

6.  Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model.

Authors:  Alexandra Litvinchuk; Tien-Phat V Huynh; Yang Shi; Rosemary J Jackson; Mary B Finn; Melissa Manis; Caroline M Francis; Ainsley C Tran; Patrick M Sullivan; Jason D Ulrich; Bradley T Hyman; Tracy Cole; David M Holtzman
Journal:  Ann Neurol       Date:  2021-02-24       Impact factor: 10.422

7.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.

Authors:  Yang Shi; Kaoru Yamada; Shane Antony Liddelow; Scott T Smith; Lingzhi Zhao; Wenjie Luo; Richard M Tsai; Salvatore Spina; Lea T Grinberg; Julio C Rojas; Gilbert Gallardo; Kairuo Wang; Joseph Roh; Grace Robinson; Mary Beth Finn; Hong Jiang; Patrick M Sullivan; Caroline Baufeld; Michael W Wood; Courtney Sutphen; Lena McCue; Chengjie Xiong; Jorge L Del-Aguila; John C Morris; Carlos Cruchaga; Anne M Fagan; Bruce L Miller; Adam L Boxer; William W Seeley; Oleg Butovsky; Ben A Barres; Steven M Paul; David M Holtzman
Journal:  Nature       Date:  2017-09-20       Impact factor: 69.504

8.  ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.

Authors:  Seong Su Kang; Eun Hee Ahn; Xia Liu; Matthew Bryson; Gary W Miller; David Weinshenker; Keqiang Ye
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 15.887

9.  Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes.

Authors:  Lianne M Reus; Bogdan Pasaniuc; Danielle Posthuma; Toni Boltz; Yolande A L Pijnenburg; Roel A Ophoff
Journal:  Biol Psychiatry       Date:  2021-01-09       Impact factor: 12.810

10.  RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila.

Authors:  Simona Langellotti; Giulia Romano; Fabian Feiguin; Francisco Ernesto Baralle; Maurizio Romano
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.